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ABSTRACT Fluorescence recovery after photobleaching (FRAP) has been used previously to investigate the kinetics of binding to
biological surfaces. The present study adapts and further develops this technique for the quantification of mass transport and
reaction parameters in bulk media. The technique's ability to obtain the bulk diffusion coefficient, concentration of binding sites,
and equilibrium binding constant for ligand/receptor interactions in the reaction limited binding regime is assessed using the
B72.3/TAG-72 monoclonal antibody/tumor associated antigen interaction as a model in vitro system. Measurements were
independently verified using fluorometry. The bulk diffusion coefficient, concentration of binding sites and equilibrium binding
constant for the system investigated were 6.1 ± 1.1 x 10-7 cm2/s, 4.4 ± 0.6 x 10-7 M, and 2.5 ± 1.6 x 107 M-1, respectively. Model
robustness and the applicability of the technique for in vivo quantification of mass transport and reaction parameters are
addressed. With a suitable animal model, it is believed that this technique is capable of quantifying mass transport and reaction
parameters in vivo.
INTRODUCTION
Mass transport and reaction govern the distribution of a
species in porous media in a wide range of applications
including oil recovery, chemical reactor design, and
cancer research. Recent theoretical (1-6) and experimen-
tal (7-10) work has investigated the importance of
transport and reaction parameters in the distribution of
therapeutic agents to diseased tissue in the human body.
In particular, it has been proposed that the various
resistances to mass transport encountered by mono-
clonal antibodies may account for their poor distribution
and limited success in detecting and treating cancer
(11). Whereas the theoretical significance of these
parameters has been established, there exist few experi-
mental techniques capable of in vivo quantification. No
technique currently exists capable of accurately and
noninvasively quantifying the diffusion coefficient and
binding parameters characterizing a therapeutic agent's
distribution in the interstitial space of a tissue. This
paper discusses the development and validation of a
photobleaching technique for the determination of the
diffusion coefficient, equilibrium binding constant, and
binding site concentration for a reaction limited binding
system. Whereas experimentation in this paper is car-
ried out in vitro, the method is general, and is amenable
to in vivo use.
There have been many in vitro measurements of
affinity binding constants and concentration of binding
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sites for monoclonal antibody/tumor associated antigen
systems. A sampling of the systems investigated, experi-
mental methods used, and their results is shown in Table
1. Most studies have used a solid phase immunoassay
technique coupled with variations of Scatchard analysis
(12). In an attempt to develop a system more representa-
tive of the in vivo environment, binding rates, and
diffusion coefficients have been quantified by measuring
the rate of uptake and subsequent washout of radiola-
beled antibodies from tumor spheroids (13). Whereas in
vitro methods have proven valuable in screening mono-
clonal antibodies and assessing their relative reactivities.
questions arise as to their usefulness in predicting in vivo
drug distribution due to differences between in vivo and
in vitro antigen expression (14-16) and mode of binding
(Kaufman, E. N., and R. K. Jain, in preparation). In vivo
data of drug concentration in plasma and tissue as a
function of time post injection has been fit to two
compartment pharmacokinetic models in order to quan-
tify the product of the equilibrium binding constant and
the concentration of binding sites (17). Such studies
model the tissue as a well mixed reactor volume. This
assumption poses an apparent contradiction. By assum-
ing the tissue as well mixed, the system is modeled as
being reaction limited. However, the models fit the data
to obtain the diffusion limited kinetic parameter (18).
Possible parameter error as a result of this discrepancy is
currently under investigation (Kaufman, E. N., and
R. K. Jain, in preparation).
It is seen that there is a need for a noninvasive, in vivo
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TABLE I Sampling of results obtained from various In vitro binding assays
System Method Results Reference
IgG anti Thy 1.1 antibody 31E6.4/AKR15 cell binding assay (12) Keq = 3.5 x 109 M-l (39)
SL2 murine lymphoma cells 5 x 105 sites/cell
IgG LS2D617/human small cell lung cell binding assay (12) Keq = 1 X 108 M-l (56)
carcinoma 2 x 106 sites/cell
IgG anti Thy 1.1 antibody 1A14/T cell cell binding assay (12) Keq = 1.6 x 109 M-l (57)
differentiation antigen
IgG antibodies/TAG-72 tumor associated solid phase immunoassay using Keq (x 109 M') (51)
antigen purified TAG-72 antigen (58) B72.3 2.5
CC92 14.3
CC49 16.2
CC83 27.1
G7A5 IgG and its fragments/A375 tumor competitive binding assay Keq(X 109 M-') Sites/cell (50)
cells IgG 12 1.5 x 105
F(ab')2 12 1.2 x i0O
Fab' 2.1 3.4 x 105
IgG anti carcinoembryonic (CEA) solid phase enzyme linked K08q(X 109 M-') (61)
antibodies/purified CEA immunoadsorbent assay (59, 60) T84.66 47
ZCE025 6.8
T84.12 5.7
IgG murine T84.66 and its human (59, 60) Keq(X 109 M-') (62)
chimeric form/purified CEA T84.66 26
Chimeric 50
IgG 36-7-5/histocompatability antigen cell binding assay (48) Keq = 5 x 108 M-' (63)
H-2Kk 2.9 x 104 sites/cell
IgG anti Lyb8.2 and its fragments/B cells cell binding assay (48) K,8q(X 109 M-') Sites/cell (9)
IgG 0.78 8 x 104
F(ab')2 0.7 4.5 x 104
Fab' 0.2 7.7 x 104
IgG anti CEA antibodies/purified CEA precipitation reaction (64) Keq's ranging from 1 x 108 to 1.4 x 109 M-' (65)
IgG 96.5/melanoma cells uptake and washout of radiolabeled kf = 2 x 10-3 s-'
antibodies from tumor spheroids Ago = 3 x 10-1 M
Notation used: Keq = equilibrium binding constant, kf = irreversible forward binding rate, Ago = molar concentration of binding sites.
measurement technique capable of quantifying mass correlation spectroscopy (FCS) have also been used to
transport and reaction parameters which accurately investigate the binding at surfaces (26-30). Works by
describe the physical situation of diffusion and immobili- Elson (31, 32) and Petersen et al. (33) review the use of
zation of therapeutic agents in the interstitial space. FRAP and FCS to measure kinetic parameters for
Fluorescence recovery after photobleaching (FRAP) interactions occurring at surfaces. Whereas TIRM tech-
offers such ability. Total internal reflection microscopy niques have been quite successful in studying two-
(TIRM) alone or combined with FRAP has been used to dimensional binding on cell surfaces, they are not
quantify diffusion coefficients and equilibrium binding designed to quantify interactions occurring in a tissue
constants for interactions occurring on glass, plastic, and mass (i.e., in bulk solution). Our laboratory has previ-
cell membrane surfaces. The theoretical model ofFRAP ously reported the development of a photobleaching
with binding was proposed by Elson and Reidler (19) technique capable of in vivo quantification of mass
and expanded by Koppel (20) and Thompson et al. (21). transport parameters. The technique's ability to quantify
TIRM has been used alone to investigate the kinetics of diffusion coefficients and convective velocities of serum
anti-DNP antibody with immobilized DNP at a surface soluble proteins has been validated in vitro (34) and
(22). This is possible when the bound complex has demonstrated in normal and tumor tissue experiments
measurably different optical properties than the individ- in vivo (35). Recently, we have extended the principles
ual species. TIRM with FRAP has been used to investi- and analysis established in the TIRM/FRAP literature
gate the adsorption of BSA on fused silica surfaces (23) to investigate the diffusion limited binding interaction of
and on PMMA and PDMS surfaces (24) as well as the Concanavalin A with immobilized mannose (18). In this
residence time of epidermal growth factor on erythro- work we further refine the measurement technique,
cyte ghost membranes (25). TIRM and fluorescence combining the benefits of video image digitization with
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conventional photomultiplier data acquisition in an
investigation of the reaction limited interaction of the
monoclonal antibody B72.3 with the tumor associated
antigen TAG-72. It is demonstrated that the reaction
limited model should correctly represent most in vivo
antibody/tumor associated antigen interactions. We re-
port the equilibrium binding constant and concentration
of binding sites for this system and discuss the potential
in vivo use of this measurement technique.
OTa
Oavg
43,,
4k:
Ap
component (n = 1 unbound, n = 2 bound; i = a
fluorescently active, i = b bleached)
Dimensionless total concentration or intensity
Dimensionless average concentration or intensity
Immobile fraction of ligand
Immobile fraction of biologically active ligand
Difference in densities between water and the
antigen beads (kg/m3)
MODEL DEVELOPMENT
GLOSSARY
Abinc Incubating concentration of antibody (Molar M)
Ag Concentration of vacant binding sites (M)
Ago Total concentration of binding sites (M)
a Radius of antigen bead (,um)
B-B72.3 BODIPY labeled B72.3 antibody
Cni Concentration of a given component (n = 1 un-
bound, n = 2 bound; i = a fluorescently active, i = b
bleached) (M)
CTa Total concentration of fluorescently active species
(M)
CTB Concentration of fluorescently active species at the
center of the bleach (M)
CTlU Concentration of fluorescently active species far
away from the bleach (M)
D Diffusion coefficient (cm2/s)
Da Damkoehler number
erf The error function
g Acceleration of gravity (m/s2)
Ini Fluorescence intensity of a given component (n = 1
unbound, n = 2 bound; i = a fluorescently active; i =
b bleached) (Gray Levels GL)
ITa Total fluorescence intensity (GL)
ITB Total fluorescence intensity at the center of the
bleach (GL)
ITU Total fluorescence intensity far away from the bleach
(GL)
'Avg Average fluorescence intensity in a given area (GL)
ki Association binding constant (M-'s-1)
k1 Dissociation binding constant (s-1)
nr Fraction of total antibody that is biologically nonre-
active
Ro Gaussian radius of the photobleach
t Time (s)
UO Bead settling velocity (,um/hour)
u Dimensionless active region half length
p Pseudoequilibrium constant
e Linearity constant between concentration and fluo-
rescent intensity (M/GL)
y Dimensionless depth of the bleach
Half length of active region
p. Viscosity of water (kg/m s)
T Dimensionless time
Oni Dimensionless concentration or intensity of a given
The binding model used in this study is identical to that
outlined by Kaufman and Jain (18). Briefly, the model
consists of the simple bimolecular interaction between
ligand and receptor as shown in Eq. 1. This model has
proven effective in modeling a wide range of biological
binding interactions (22, 27, 36, 37). The diffusion
equation with reversible binding to one type of site
assuming a uniform distribution of binding sites, biologi-
cally active bleached molecules, immobile bound com-
plex, no convective field, and no metabolism of the
ligand or bound complex is (the validity of these assump-
tions for both in vitro and in vivo experiments have been
addressed in [18]):
k,
Cli + Ag *
k-I
-cl DV2C,, - kICI,Ag + k-,C2i
a
=2 k,Cl,Ag k-IC2i.
(1)
(2)
(3)
These equations' must be written for both fluorescently
active (i = a) and bleached (i = b) macromolecules
because bleached molecules are assumed to be biologi-
cally active. Experimentally, it is fluorescence intensity
and not concentration that is measured. If the measured
fluorescence intensity is linear with the concentration of
fluorescently active macromolecule and is forced to have
a zero intercept by background subtraction, concentra-
tions may be rewritten in terms of the measured fluores-
cence intensity: Cni = EI,. Epsilon is the linearity
constant between concentration and fluorescence inten-
sity.
As discussed in (18), the geometry of the system is
cylindrical with dependence only in the radial direction
'C,i = concentration of mobile macromolecule
C2, = concentration of immobile (bound) macromolecule
Ag = concentration of vacant binding sites
Ago = total concentration of binding sites
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(r) so that:
1 a ac
V2C=--r-a. (4)
r ar ar
The initial conditions are imposed by the Gaussian
intensity profile of the laser beam and by the assumption
that the bound and unbound components are in equilib-
rium and are bleached to the same extent.2 The bound-
ary conditions are:
ac1, ac2,
ar =-y=O at r=O and as r-x. (5)ar ar
The recovery equations are rearranged so that the
dimensionless average intensity reaches a value of 1 as
t -+ cc, for a completely mobile system. The mathemati-
cal model of binding yields four coupled, nonlinear,
partial differential equations describing the recovery of
each of the four components (mobile fluorescently
active, mobile bleached, bound active, and bound
bleached). The recovery equation for the mobile active
component is shown below.3 (The Laplacian operator in
Eq. 6 is dimensionless due to the fact that the length
scale has been normalized with respect to R. (see
reference 18).) The remaining three equations are
similar in form. Note the four contributions to the
fluorescence recovery: diffusion, binding to unsaturated
sites, negation of the association reaction due to satura-
tion, and the dissociation reaction.
aO. DV20i - kjAg0Oiaat R2 la
Diffusion Association
+ k,E(ITU - ITB)0la(02a + 02b + _Y) + k-1(02 + y) (6)
Saturation Disocciation
2CTa(r, t = 0) = CTB+ (Cu- CTB) [1 - exp (Zj)]
CTi = total concentration of macromolecule = C1l + C2, (the fluores-
cence intensity ITa = Ila + I2. is measured)
Cu = total concentration of fluorescently active macromolecule well
beyond the bleached region
CTB = total concentration of fluorescently active macromolecules at
r = 0 and t = 0
R. = radius of the bleached spot at t = 0 such that CT(RO, t = 0) =
(1 - 1Ie2)CR,,, i.e., the Gaussian radius of the bleach
3y is the dimensionless depth of the bleach defined as: y = C /(C-V -
CrB)
Oia = dimensionless intensity of mobile, fluorescently active macromol-
ecule = Ila(ITu- ITB)
Ou = dimensionless intensity of bound, fluorescently active macromol-
ecules = (I2 - ITB)/(ITU - ITB)
02b = dimensionless intensity of bound, bleached macromolecule =
I2b/(VTU -ITB)
LIMITING CASES-ANALYTICAL SOLUTIONS
Analytical solutions to the above mathematical model
have been derived for the three cases of (a) no binding,
(b) diffusion limited binding, and (c) reaction limited
binding. When no binding occurs, the simplified partial
differential equations are easily solved using Fourier
Transforms to yield the dimensionless fluorescence
intensity as a function of space and time (35). This
equation may be spatially integrated (18) to yield the
dimensionless average fluorescence intensity (OAvg) in a
square region of length 2t centered about the bleach as
a function of time:
'Avg=I TB = rr 2f2 uOAvg
T
1-L- ~erf (7)
where
+/it ~Dt
u= and T =
Dt
R?, R 2
It is the quantity IAVg that is measured during the
photobleaching recovery.
When the system is diffusion limited (Damkoehler
Number = Da = (k,Ag0R'/D) > 1 and system far from
saturation) the bound and unbound components are
rapidly exchanged and exist in equilibrium. Crank (38)
demonstrates that such systems may be represented by
the same solutions as for nonbinding regimes if the
diffusion coefficient is replaced by an effective diffusion
coefficient: Deff = DI1 + P where = k,Ago/k-l. Thus,
diffusion limited binding systems are expected to have
an asymptotic recovery to a value of OAvg = 1 and are
characterized by a single parameter, the effective diffu-
sion coefficient. By measuring the effective diffusion
coefficient and the diffusion coefficient of a nonbinding
system, the product of the equilibrium constant and
concentration of binding sites may be obtained (18). It
has been shown (5) that ,1 is the kinetic parameter of
interest in predicting in vivo antibody distribution on
macroscopic length and long time scales.
When the system is reaction limited (Da << 1) a given
molecule exists in either the bound or unbound state
with negligible exchange on the time scale of the
fluorescence recovery. In this case, a fraction f0 of the
total molecules are effectively immobile on the time
scale of the experiment. The dimensionless average
fluorescence intensity OAvg for such a system will asymp-
totically approach a value less than unity due to the
immobilized fraction which is not able to recover. In
such a system, the kinetic parameters in the transient
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equations may be neglected for short time scales and an
analytical solution obtained. 0,,9 for a reaction limited
system will be equal to:
OAvg = (fraction mobile)
x (recovery equation for mobile molecules)
+ (fraction immobile)
x (dimensionless average intensity at t = 0)
or:
IA,Ag -IAAvg= Tel
TU TB
-
8(1 - oe ) + oerf2uJ (8)
The reaction limited system is thus characterized by two
parameters, 4. and D.
It is well known (12, 39, 40) that in the production,
purification, labeling and storage of monoclonal antibod-
ies, a given fraction of the labeled antibody will be
rendered biologically inactive and will not be able to
bind to its antigenic site. If nonreactive fraction data is
available, it is appropriate to report the immobile
fraction as the fraction of biologically active molecules
which are immobile ((c) rather than merely 4. If nr is
the fraction of antibody rendered biologically inactive
then:
1-nr (9)
The immobile fraction 4c is a function of the equilib-
rium constant for immobilization (K,), the total concen-
tration of binding sites (Ag,), and the concentration of
biologically active antibody (Abin,) in the system. By
definition:
& ~~~~C2 + C2, 10
q (Abinc - C2a - C2b)(Ago - C2a - C2b) (10)
upon rearrangement:
C2, + C2b
cAbinc
1 + Kq(Ago + Abinc) ((1 + Keq(Ago + Abinc)2 4Ag\0.5
KeqAbinc K qAbinc | Abinc)
2
The equilibrium binding constant and concentration
of binding sites can thus be obtained by measuring 4X as
a function of incubating antibody concentration. In in
vitro experiments, these parameters may also be ob-
tained by measuring jc at various dilutions of the
antigen.
SAMPLES
IgG (molecular weight 150,000) monoclonal antibody
B72.3 (41) was the gift of Dr. B. Rhodes (RhoMed Inc.,
Albuquerque, NM).4 The antibody was custom labeled
with Boro Dipyro Methane Difluoride (BODIPY) fluo-
rescent probe (Molecular Probes, Inc., Eugene, OR) to
a dye to protein ratio of 2.93 and an antibody concentra-
tion of 0.42 mg/ml (2.8 x 10-6 M). Bovine Serum
Albumin (1%) and Sodium Azide (2 mM) were added to
the stock antibody to aid protein stability and inhibit
bacterial growth. Antibody was stored at -72°C. Once
thawed or incubated with antigen beads, samples were
stored at 5°C. To measure the free diffusion coefficient
of BODIPY B72.3, the stock solution of labeled anti-
body was drawn into a 200 ,um thick glass capillary slide
(model #W3520; Vitro Dynamics, Rockaway, NJ) for
observation conducted at 23 ± 2°C. For B72.3 binding
experiments, tumor homogenate containing tumor asso-
ciated or irrelevant antigen immobilized to 5 ,um diame-
ter beads (RhoCheck Lot #J032990L1) donated by
RhoMed Inc. was utilized as the immobilized antigen
component. The beads were supplied as a 2% by volume
solution of beads in PBS and 1% BSA. In binding
experiments, an appropriate mixture of specific or con-
trol (irrelevant antigen) beads and a wash solution (PBS
and 1% BSA supplied as part of the RhoCheck product)
totaling 1.0 ml was centrifuged in order to concentrate
the antigen beads. By altering the bead/wash solution
mixture, various final bead concentrations were ob-
tained. After centrifugation, 940 pAl of the supernatant
was removed and 50 [lI of stock B72.3 antibody was then
added. Samples were incubated at 5°C for at least 12 h
before experimentation. As in the free diffusion experi-
ments, samples were drawn into 200 ,um thick capillary
slides for observation at 23 + 2°C. The capillary slide
was inverted after each bleach (every 10 min) to avoid
settling of the beads which would occur if the slide was
left undisturbed for an hour or more. This experimen-
tally observed settling time is in agreement with esti-
4B72.3 is an IgGI (51). The antibody provided was purified from
ascities fluid and aggregates were removed (personal communication,
Dr. B. A. Rhodes, RhoMed Inc.). Free dye was removed during the
custom labeling process (personal communication Dr. Rosaria Hau-
gland, Molecular Probes Inc.), but was not assayed before photobleach-
ing. The presence of free dye would be evidenced in a biphasic
fluorescence recovery which was not seen experimentally.
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mates assuming Stokes flow at infinite dilution.5 Using
this protocol, samples containing 18, 13.5,9, and 4.5% by
volume beads in 1.3 x 10-6 M antibody were obtained.
In some experiments, the incubating antibody concentra-
tion was decreased in order to obtain larger immobile
fractions.
cally controlled via the IBM PC-AT were used to control
the bleaching time and light reaching the camera. The
laser power was typically 0.36 mW after its passage
through the spatial filter and objective. The 12% neutral
density filter reduced the power impinging upon the
sample to 0.04 mW whereas the 50% neutral density
filter reduced the power to 0.18 mW.
EQUIPMENT FOR FRAP
The equipment, experimental procedure, and data anal-
ysis technique used in this study are those used and
proposed by Kaufman and Jain (18). Briefly, the capil-
lary slide was transilluminated for monitoring purposes
at 480 nm by a mercury vapor lamp (Model HBO 100W;
Zeiss, Morgan Instruments, Cincinnati, OH). Light
passed through a heat reflector (Model Califax; Zeiss,
Morgan Instruments), heat absorber (Model KG-1;
Zeiss, Morgan Instruments), FITC exciter and red
absorber filters (Models 46-79-79 and 46-78-85; Zeiss,
Morgan Instruments). The microscope was focused on
the sample using a 20X objective (Model F-LD 20/0.25;
46-06-05; Zeiss, Morgan Instruments). Light emitted
from the sample was passed through a barrier filter
(Model 46-78-33; Zeiss, Morgan Instruments) and the
1.25X lens in a Zeiss Optovar (Model 47-16-45; Zeiss,
Morgan Instruments) installed in the microscope barrel.
The image was monitored using an intensified charge
coupled device (ICCD) camera (Model C2400-97; Hama-
matsu, Photonic Microscopy Inc., Oak Brook, IL) oper-
ated in a range where measured intensity was linear with
fluorophore concentration. The video signal was sent to
an image analysis system (Model DT-IRIS; Data Trans-
lation, Marlboro, MA) housed in an IBM PC-AT allow-
ing on-line digital analysis of the image.
A 5 W argon ion laser (488 nm) (Model 2000-5;
Spectra Physics, Mountain View, CA) was used to
photobleach the sample. The laser beam was directed
through a spatial filter (Model 900; Newport Corp.,
Fountain Valley, CA) containing a 1oX objective (Model
M-1OX; Newport Corp.) and a 25 ,um pinhole aperture
(Model 900PH-25; Newport Corp.). The beam was then
focused using a 5X microscope objective (Model M-5X;
Newport Corp.) and accessed the sample via the epiillu-
mination port of the microscope where it was attenuated
using neutral density filters (Models 46-78-40, -41, -42,
Zeiss, Morgan Instruments). Two shutters (Uniblitz
Electronic, Vincent Assoc., Rochester, NY) electroni-
'U. = (2a2Apg/9p.) = 59 p.m/h when a = 2.5 p.m, Ap = 1.21 kg/m3
(assuming the particles are glass), g = 9.8 m/s2, and p. = 0.001 (kg/m s).
Smaller velocities would be calculated if the finite volume fraction of
the antigen beads was taken into account.
EXPERIMENTAL PROCEDURE
After prefluorescent and prebleach (background) image
acquisition and storage, a region in the sample was
photobleached for 0.08-0.18 s. Upon closing the laser
shutter, the camera shutter was opened to allow imaging
of the sample. Single video frames were acquired as
rapidly as allowed by the acquisition board, requiring
0.16 s for each frame. The fluorescence intensity data
from the active region (Fig. 1) was stored in the system
buffers. To correct for nonuniform camera response or
possible bleaching of the sample due to excitation light
during fluorescence recovery, data was also obtained
from a "control region" (Fig. 1). The process of data
acquisition was continued for 24 s after the photobleach.
After acquisition, background image subtraction, and
correction for possible photobleaching due to the excita-
tion light source, the 90 x 70 intensity data from the first
time point were low pass filtered and a minimum in
fluorescence intensity found in order to estimate the
location of the bleached spot relative to the 90 x 70 pixel
field. The bleach location was used to select a 36 x 29
70
. .. . .
29
90 .36 _
36
FIGURE 1 Data acquisition areas. The active region consisted of a
90 x 70 pixel (69 x 69 ,um) area containing the bleached spot. Once
the center point location of the bleach was estimated, data was
collected from a 36 x 29 pixel (28 x 28 pm) active region properly
centered about the bleach. A 28 x 28 ,um control region was located
along the vector passing through the active region and the center of the
field of view and was placed so that it was an equal distance from the
center of the field of view as the active region.
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pixel region properly centered about the photobleach
(Fig. 1). The fluorescent intensity data in the 36 x 29
pixel region for the first time point as well as the average
intensity in each 36 x 29 pixel region as a function of
time were stored for subsequent analysis.
ANALYSIS PROCEDURE
Data analysis was performed on a Sun 3/260 workstation
(Sun Microsystems Inc., Mountain View, CA). A Gauss-
ian profile was fit to the intensity data as a function of
position from the first time point using the Levenberg-
Marquardt (42, 43) nonlinear parameter estimation
method. This fit determined the parameters R. and IB
which were used to convert the data into dimensionless
form and to calculate the dimensionless active region
size u. The diffusion coefficient and fraction of antibody
which was immobile on the length scale of the recovery
were obtained by using the Levenberg-Marquardt
method to minimize the sum of squares error between
the model (Eq. 8) and the dimensionless average fluores-
cence intensity in the active region as a function of time.
FLUOROMETRY
Fluorometry experiments were undertaken to indepen-
dently verify the immobile fractions obtained in photo-
bleaching experiments and to quantify the fraction of
antibody which was biologically inactive. These experi-
ments measured the fluorescence intensities of the
antibody/bead mixtures before and after unbound anti-
body was washed from the samples in order to obtain the
fraction of antibody bound to the antigen beads. The
fluorescence intensity was measured using a lumines-
cence spectrometer (Model LS-5B; Perkin Elmer, Nor-
walk, CT) with 490/520 nm excitation and emission
wavelengths. A 45 [LI cuvette (Model 105.251.QS; Hellma
Cells Inc., Forest Hills, NY) contained the specimen.
The zero level was first set using a solution of antigen
beads containing no antibody at a volume percent equal
to that of the sample to be tested. The fluorescence
intensity of the antibody/bead sample was then mea-
sured. The sample was washed of free antibody by
centrifuging the sample, discarding the supernatant and
replacing it with an equal volume of wash solution. This
process was repeated three times after which the fluores-
cence intensity attributed to the bound antibody was
measured in the spectrofluorometer. The fluorescence
intensity attributed to the bound antibody divided by the
initial measurement of total fluorescence intensity in the
sample represents the fraction of antibody bound to the
TABLE 2 Results of photobleaching experiments
Sample D ( x 10 cm2/s) 40. n
(1) 5.75 ±0.72 0.04 0.04 29
(2) 6.46 ± 1.06 0.11 ±0.05 16
(3) 6.17 1.17 0.31 ±0.11 16
(4) 6.57 + 1.05 0.26 +0.05 12
(5) 6.22 1.30 0.16 0.03 8
(6) 5.74 1.14 0.12 0.03 12
(7) 6.23 ± 1.60 0.34 +0.06 13
Values are reported as mean ± standard deviation, D = diffusion
coefficient, O = uncorrected immobile fraction and n = number of
bleaches. Sample identification is as follows: 1) 1.3 x 10-6M BODIPY
(B)-B72.3 2) 18% by volume control antigen beads in 1.3 x 10-6 M
B-B72.3 3) 18% by volume specific antigen beads in 1.3 x 10-6 M
B-B72.3 4) 13.5% by volume specific antigen beads in 1.3 x 10-6 M
B-B72.3 5) 9% by volume specific antigen beads in 1.3 x 10-6 M
B-B72.3 6) 4.5% by volume specific antigen beads in 1.3 x 10-6 M
B-B72.3 7) 18% by volume specific antigen beads in 3.25 x 10' M
B-B72.3.
antigen beads (k). Photobleaching and fluorometry
experiments used identical sample preparations. To
obtain the fraction of antibody unable to bind, a sample
containing 18% by volume TAG-72 beads in 1.3 x 10-8
M B-B72.3 antibody was used. It was assumed (see
Discussion) that for a sufficiently large equilibrium
binding constant and concentration of binding sites that
nearly all of the biologically active macromolecule would
be bound in this environment. Under this assumption,
the immobile fraction measured represented the frac-
tion of antibody biologically active.
RESULTS
The diffusion coefficients and immobile fractions ob-
tained by photobleaching experiments are shown in
Table 2. Representative Gaussian profiles and fluores-
cence recovery curves are shown in Fig. 2. The measured
diffusion coefficient of the B72.3 antibody was indepen-
dent of sample preparation6 and measured immobile
fraction (one way analysis of variance F statistic = 1.32
with dft = 6 and dfe = 99. p 3.75 at a level of 0.05).
Small yet significant immobilization of the antibody on
the glass surface was evidenced by an immobile fraction
of four percent in the free antibody experiments. Signifi-
cant immobilization was also noted in the irrelevant
6As discussed in reference 38, the diffusion coefficient should be a
decreasing function of the volume fraction of beads. For a periodic
distribution of spheres at 18% by volume, the diffusion coefficient is
expected to be reduced by 25%. This was not seen in our data due to
the fact that the length scale of the photobleach does not discern the
bead distribution as a lattice.
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FIGURE 2 Photobleaching recovery. (a and c) Intensity data as a function of position for the first time point was fit to a Gaussian function in order
to obtain the geometric parameters Ro and ITB . (b and d) Dimensionless average fluorescence intensity data as a function of time was fit to Eq. 8 to
determine the diffusion coefficient and immobile fraction. a and b represent a photobleach of 2.8 x 10-6 M B-B72.3 which yielded R. = 38.4 + 0.8
Am, ITB = 50.0 + 0.1 GS, D = 6.08 + 0.28 x 10-7 cm2/s and 4O. = 0.03 ± 0.01. c and d are from a bleach of a solution containing 18% by volume
antigen beads in 3.25 x 10-7M B-B72.3. Measured parameters for this bleach were R. = 35.1 ± 1.7 pm, ITB = 32.3 -+ 0.1 GS,D = 8.21 + 1.05 x 10-7
cm2/s and k = 0.41 + 0.02.
antigen sample. Immobile fractions measured by fluo-
rometry were not statistically different from those ob-
tained through photobleaching (student's t-test p >
0.1). In addition, fluorometry experiments demonstrated
that 65% of the fluorescently active material was biolog-
ically inactive.
To quantify the equilibrium constant and concentra-
tion of binding sites for the interaction of biologically
active B-B72.3 antibody with TAG-72 antigen beads, the
4% immobilization due to binding to the glass surface
was subtracted from each fO measurement, and 4,
calculated using Eq. 9 with nr = 0.65. The incubating
antibody concentration was corrected to account for
biologically inactive antibody. Photobleaching data of Xc
versus antigen dilution factor and incubating antibody
concentration was fit to Eq. 11 using a nonlinear
regression package (44) to yield the equilibrium binding
constant and concentration of binding sites. Analysis of
the covariance matrix indicated that these parameters
operated independently with respect to predicting the
data (44). An antigen dilution factor of 1.0 corresponded
to a 18% by volume solution of antigen beads. Both
antigen dilution factor and antibody concentration were
independent parameters in fitting to Eq. 11 and all data
were fit simultaneously. For purposes of display, c
versus antigen dilution factor at constant antibody con-
centration and c versus incubating antibody concentra-
tion at constant antigen dilution factor are shown
separately in Fig. 3. The photobleaching experiments
yielded an antigen concentration of 4.4 + 0.6 x 10-7 M
for an 18% by volume solution of test beads and an
equilibrium binding constant for the B-B72.3/TAG-72
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FIGURE 3 Fit to obtain Keq and Ag. Nonreactive antibody corrected
immobile fractions (4c) as a function of antigen dilution at constant
incubating antibody concentration and as a function of incubating
antibody concentration at constant antigen concentration were fit to
Eq. 11 to obtain the equilibrium binding constant and antigen
concentration for an 18% by volume solution of antigen beads. This
procedure yielded Keq = 2.5 ± 1.6 x 107 M' and Ago = 4.4 ± 0.6 x
10-7 M. Error bars on the data represent the standard deviation of the
measurement. "Antigen Dilution Factor" refers to the relative de-
crease in antigen concentration with respect to 18% by volume antigen
beads. For example, a dilution factor of 0.5 represents a 9% by volume
solution.
bead interaction of 2.5 + 1.6 x 107 M-'. Kinetic
parameters obtained from fluorometry experiments were
not statistically different (student's t-test p > 0.1). The
average value of the diffusion coefficient for B-B72.3
antibody from all samples was 6.11 + 1.12 x 10-7 cm2/s
(n = 106).
DISCUSSION
Independent measurement and
possible FRAP experimental artifacts
Several factors were investigated to ensure that the
immobile fraction obtained by photobleaching methods
truly represented the fraction of fluorescently and biolog-
ically active antibody bound to the antigen beads.
Immobile fractions were independently obtained through
fluorometry experiments, and potential experimental
artifacts were addressed. The immobile fractions ob-
tained through fluorometry were in no case statistically
different from those obtained in photobleaching experi-
ments. Potential inaccuracy of fluorometry measure-
ments due to antibody dissociation during the washing
process of conversely, incomplete washing of the free
antibody was not evidenced. Experimental artifacts
could potentially cause error in the measurement of
immobile fractions using FRAP. Bleaching of the speci-
men caused by the excitation (monitoring) light source
during the process of fluorescence recovery would lead
to an overestimation of the immobile fraction. The use
of video image digitization enabled correction for this
phenomena as data was acquired. In this study, the use
of a control region placed apart from the photobleached
spot, yet at an equal radius from the center of the field of
view, corrected for factors influencing fluorescence inten-
sity other than the fluorescence recovery process. To
demonstrate that this control region correctly compen-
sated for excitation bleaching, the algorithm was tested
by its ability to report a constant fluorescence intensity
in the active region as the sample was exposed to
excitation light for a period of 100 s without prior
bleaching from the laser. Fig. 4 demonstrates that the
correction algorithm maintains constant fluorescence
intensity readings and the possible error incurred by
neglecting excitation bleaching. Previous studies have
addressed potential protein cross-linking and laser in-
duced photodamage (45, 46) and have discussed the
implications of a limited domain or reservoir of fluores-
1.1
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FIGURE 4 Test of control region correction algorithm. Sample contain-
ing 4.5% by volume antigen beads in 1.3 x 10-6 M BODIPY B-B72.3
antibody was excited with the same transillumination source as used in
photobleaching experiments. Average fluorescence intensity data was
acquired from an active region and control region located equidistant
from the center of the field of view as the active region. The variation
from the initial fluorescence intensity in the control region was
calculated at each time point and the intensity in the active region
corrected by this fractional change. Shown above is the corrected and
uncorrected fluorescence intensity as a fraction of its initial value with
time. Note that the correction algorithm maintains the intensity at its
initial value, correcting for excitation bleaching and reducing random
fluctuations.
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cent macromolecule in the photobleached area (32).
Both protein cross-linking and a limited domain would
lead to an overestimation of the true immobile fraction
of antibody. However, in our experiments, immobile
fractions were not seen to increase with increased bleach
exposure or repeated photobleaches at the same loca-
tion.
Validity of reaction limited model
Errors in mass transport and reaction parameters can be
incurred if the model of binding employed does not
properly represent the interaction investigated. Good-
ness of fit alone can not be used as the sole criteria for
determining the validity of a model, especially given the
rather featureless shape of the fluorescence recovery
curve. To investigate the validity of the reaction limited
model, theoretical data were generated by numerical
solution to the full set of partial differential equations
describing fluorescence recovery (Eq. 6) and were fit to
the reaction limited model (Eq. 8). The model's ability
to correctly determine the diffusion coefficient and
immobile fraction defined by the parameters used to
generate the data established the range of validity of the
reaction limited model. The reaction limited binding
model assumes that diffusion is the dominant mode of
fluorescence recovery on the time scale that the photo-
bleach is monitored and that low frequency components
of recovery due to binding interactions may be neglected
without incurring error in measured diffusion coeffi-
cients or immobile fractions. Thus, the greater the
magnitude of the diffusive component of fluorescence
recovery, the greater the accuracy of the reaction limited
model. The relative significance of the diffusive term has
both spatial and temporal considerations. The magni-
tude of the diffusive term is a function of the Laplacian
operator for the dimensionless concentration of mobile
macromolecule. Due to the Gaussian initial condition,
V20la decreased with distance from the bleach center. In
addition, V20la also decreases with time as the gradient
in fluorescence intensity relaxes, further lessening the
contribution of the diffusive term and increasing the
relative significance of the kinetic terms. Thus, the size
of the active region and the monitoring time employed
are important factors in determining the applicability of
the reaction limited model. Simulations were conducted
using parameter values representative of the photo-
bleaching experimental conditions. The initial Gaussian
radius of the bleach was set at 40 ,um, the dimensionless
active region size equal to 0.5, and the data generated
for a period of 20 s.
In general, the reaction limited model correctly pre-
dicted the diffusion coefficient and immobile fraction for
systems whose Damkoehler number was less than unity.
These systems were characterized by a dominance of the
diffusive term in the recovery equations (Fig. 5). For
theoretically generated systems whose Damkoehler num-
ber was between 1 and 50, the model fit the recovery
data well but yielded inaccurate parameters (Fig. 6). For
larger Da, the reaction limited binding model was
incapable of fitting the recovery data. Even when the
Damkoehler number was less than unity, low extents of
saturation caused slight error (- 10%) in obtaining the
diffusion coefficient due to the decreased significance of
the diffusive term. When the reaction limited model was
applied to theoretically generated nonreaction limited
binding systems, the resulting diffusion coefficients and
immobile fractions were seen to be functions of monitor-
ing time due to the varying importance of the diffusive
term (see caption of Fig. 6). This fact was used as a
diagnostic to check the validity using the reaction limited
model in the B72.3/TAG-72 binding system. Recovery
curves for all of the experimental data were reanalyzed
using only the data from the first 12 rather than 24 s. In
no case were there significantly differences in the fitted
parameters with decreased monitoring time (student's
t-testp > 0.05), indicating that the experimental system
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FIGURE 5 Order of magnitude of various kinetic contributions to
fluorescence recovery at bleach periphery for a low Damkoehler
number system. Theoretical simulation was conducted with the follow-
ing parameter values: D = 6.1 x 10' cm2/s, R. = 4 x 10' cm, Ago =
4.4 x 10-7 M, u = 0.5, ITU = 50 GS, ITB = 37.5 GS, e = 9.1 x 10-9 M -
GS-', k, = 2.5 x 103 M`-l s-' and k-, = 1 x 10-4 s-'. Order of
magnitude of diffusion, free association, saturation and dissociation
terms at the bleach periphery as a function of time were calculated
numerically. The diffusive terms dominates the fluorescence recovery,
especially at early time. The predominance of the diffusive term is even
greater at locations toward the center of the bleach. Note also the log
axis which visually understates the dominance of the diffusive term. In
this simulation, Da = 0.03 and the reaction limited model correctly
predicts a diffusion coefficient and immobile fraction of 6.1 x 10-7
cm2/s and 0.73, respectively, when the data is analyzed for 10 or 20 s.
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FIGURE 6 Order of magnitude of various kinetic contributions to
fluorescence recovery at bleach periphery for a medium Damkoehler
number system. Theoretical simulation was conducted with the follow-
ing parameter values: D = 6.1 x 10-' cm2/s, R. = 4 x 10-3 cm, Ago =
4.4 x 10- M, u = 0.5, ITU = 50 GS, ITB = 37.5 GS, E = 9.1 x 10-9M-
GS', k1 = 2.5 x 106 M s' and k-1 = 1 x 10' s'. Order of
magnitude of diffusion, free association, saturation, and dissociation
terms at the bleach periphery as a function of time were calculated
numerically. The kinetic terms dominate the fluorescence recovery. In
this simulation, Da = 28.9 and whereas the reaction limited model may
fit the recovery data well, it yields incorrect parameters. When the
reaction limited model is incorrectly applied, the parameters are seen
to be functions of time. When the data were analyzed for 20 seconds,
the reaction limited model gave a diffusion coefficient of 1.2 x 10-7
cm2/s and an immobile fraction of 0.05. When only the first 10 s of data
were fit, the reaction limited model yielded D = 1.8 x 10-7 cm2/s and
+ = 0.29. Varying parameter values as a function of time may be used
as a diagnostic for the proper use of the reaction limited model.
was well characterized by the reaction limited binding
model (Fig. 7).
Nonreactive fraction and free antigen
In any protein preparation, a fraction of the protein
present will lack the biological reactivity under investiga-
tion. This is especially true in studies of labeled antibod-
ies where purification, labeling, and storage, as well as
the possible presence of labeled carrier protein such as
BSA will lead to a fraction of the total fluorescent
material being inactive in the sense of specific antibody
reactivity. The magnitude of the nonreactive fraction
must be accounted for to avoid error in estimating the
concentration of binding sites and the antibody affinity
(12, 39). In this study, if it were assumed that 100% of
the fluorescently active material was capable of immobi-
lization to the antigen beads, an equilibrium binding
constant of 3.12 + 1.53 x 105 M` and a binding site
concentration of 1.48 + 0.59 x 10-6 M would have been
obtained. In this study and in the commercial procedure
FIGURE 7 Diagnostic of reaction limited model with experimental
data. When the reaction limited model is applied to nonreaction
limited data, the mass transport and kinetic parameters obtained will
be functions of monitoring time. Photobleaching data were reanalyzed
using only the first 12 s of data rather than the full 24. There was no
statistical difference between the parameters obtained from different
monitoring times, confirming a reaction limited binding regime. Shown
here is a fluorescence recovery curve (dimensionless average fluores-
cence intensity versus time) from a system composed of 13.5% by
volume specific antigen beads in 1.3 x 106 M B-B72.3 antibody. The
reaction limited model yields D = 5.6 x 10' cm2/s and 4 = 0.18
regardless of monitoring time.
for determining immunoreactivity (40) it is assumed that
for low extent of saturation, all of the biological active
antibody will be immobilized to the antigen beads. As
can be demonstrated using Eq. 11, this assumption is not
valid for small equilibrium binding constants. Significant
error in estimating kinetic variables can occur if the
nonreactive fraction is overestimated by attributing
unbound antibody to a nonreactive fraction if it in fact is
due to a small equilibrium constant for the receptor/
ligand interaction. In this study, supernatants from the
reactivity assay washes were assessed for biological
activity. These supernatants lacked measurable reactiv-
ity to antigen specific beads, confirming the assumption
that under the conditions of the reactivity experiment,
all biologically active antibody was immobile and the
reactivity assay was accurate.
Another possible confounding variable in these exper-
iments is the possibility of antigen which has dissociated
form the bead surface and is no longer immobile. This
would lead to an overestimation of the nonreactive
fraction and hence an overestimation of the kinetic
parameters. The presence of free antigen would also
tend to decrease the measured diffusion coefficient of
the antibody due to the increased molecular weight of
mobile antibody/antigen complexes. This phenomenon
can easily be avoided by washing the antigen beads
before antibody incubation but was not performed in
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these experiments. We do not believe that appreciable
free antigen was present in our binding samples how-
ever, due to the fact that the diffusion coefficient
obtained in the absence of antigen beads was not
significantly different than those obtained in binding
samples.
Bivalent binding
The mathematical model of binding used in this study
assumes that the equilibrium binding constant of the
ligand/receptor interaction may be characterized by a
single immobilization reaction. Because the B72.3 anti-
body is an IgG antibody, capable of bivalent antigenic
binding, this assumption must be further investigated. It
is seen that the occurrence of bivalent binding may be
the major cause of discrepancies in equilibrium con-
stants obtained by different laboratories, underscoring
the need to characterize kinetics in the specific system of
interest. The ability of an IgG antibody to bind bivalently
at a surface will depend in a complex manner upon the
antibody and receptor bulk concentration, the distance
between binding sites on both the ligand and receptor,
and the particular kinetic rate constants of the interac-
tion (47). Bivalent binding will predominate when the
density of vacant antigen on the surface is high, but will
decrease with increasing degrees of saturation and
increasing distances between neighboring antigenic sites
on the surface. Obviously, the ability to bind bivalently
will increase the overall effective equilibrium binding
constant for immobilization of the ligand. Work by
Dower et al. (48, 49) demonstrates an "enhancement
factor" due to the presence of a mixture of bivalent and
monovalent immobilization. Perelson et al. (47) and
Pisarchick and Thompson (22) show that the effective
equlibrium binding constant can be as high as the
product of the two equilibrium constants for each
immobilization step when bivalent binding is the predom-
inant mechanism. This difference in affinity has been
evidenced in differences in the effective equilibrium
constants between an intact IgG molecule and its
monovalent fragment (9, 48, 50) (see Table 1). If the
equilibrium binding constant is 1 x 107 M` for a totally
monovalent system, it is thus conceivable that the
effective equilibrium constant in the presence of high
antigen density and totally bivalent interaction could
reach 1 x 1014 M-l. The fact that the equilibrium binding
constant reported here for the B72.3/TAG-72 binding
systems is two orders of magnitude lower than that
reported by Muraro et al. (51) is not surprising given the
fact that Muraro's study used purified TAG-72 antigen
immobilized at high density whereas this investigation
utilized tumor homogenates immobilized to microscopic
beads.
Potential in vivo use
The proposed photobleaching technique allows the
quantification ofbulk mass transport and reaction param-
eters in diffusion and reaction limited binding regimes.
Unlike other techniques, it does not require measurable
physical changes in the optical properties of the bound
complex. Coupled with an appropriate animal model
such as the rabbit ear chamber (52) or rat/mouse dorsal
chamber tissue preparation (53), possessing an identi-
fied antibody/antigen interaction, this technique could
be capable of in vivo quantification of mass transport
and reaction parameters. Various assumptions of the
proposed model as applied in vivo experimentation
including neglecting convective flow, uniform distribu-
tion of binding sites, nonspecific binding, and thermal
effects have been described previously (18). It is ex-
pected that in vivo, most antibody/antigen interactions
will be well characterized by the reaction limited binding
model. In vitro investigations have reported antigen
densities on the order of 1 x 105 binding sites per cell
(see Table 1). If the cellular volume fraction of the
interstitial space is 50% and cells are assumed to have a
diameter of 15 pLm, this would translate into an antigen
concentration of -5 x 10' M. This small antigen
concentration leads to small Damkoehler numbers and
reaction limited binding regimes for most experimental
conditions. It has been suggested by Koppel (20) that a
reaction limited system could be rendered diffusion
limited by increasing the length scale of the system (R.
for our purposes). This would be impractical in vivo
where the length scale of the bleach is limited by the
proximity of blood vessels which would contribute signif-
icant error were they to lay in the photobleached area.
At this point, it does not appear that individual rate
constants may be determined from a single photobleach
as we originally suggested (18). Components of fluores-
cence recovery due to association or dissociation are not
discernable from that of diffusion in our current experi-
mental protocol. This study obtained Keq and Ago by
measuring 4c while varying both the antibody concentra-
tion and antigen dilution factor. In vivo these parame-
ters would have to be obtained by slowly increasing
antibody dosage and measuring as a function of
antibody concentration in the interstitial space (54) as
new steady states are reached after each bolus injection
of antibody. As seen in reference 22 and demonstrated
in this work, it is data at high values of 4, that truly
define the equilibrium binding constant. Theoretically,
in Eq. 11 only two data points are needed to determine
the two unknown parameters, yet realistically, several
data points covering a wide range of 4c values must be
obtained for accurate determination of the equilibrium
binding constant and concentration of binding sites. It
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remains to be seen if this can be accomplished in vivo.
Animal experiments to determine kinetic variables must
possess an in vitro immobilization assay for the particu-
lar antibody/antigen system under investigation such as
that discussed by Rhodes et al. (40) in order to report
"true" kinetic constants. As discussed, the presence of
nonreactive antibody will affect apparent antibody/
antigen interaction. In cancer therapy, the presence of
nonreactive antibody will also affect antibody uptake
ratios in normal and tumor tissues (55).
This study, in combination with our previous work
(18), has established the mathematical and experimental
framework for the use of photobleaching to measure
mass transport and reaction parameters in the bulk
solution of the interstitial space in vivo. It is hoped that
improved methods of cancer detection and treatment
will result from the ability to accurately determine these
parameters in the clinically realistic environment that
this photobleaching technique affords.
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